Author

Christie Perelló

EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE
EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE

Christie Perelló  et al.

EARLY SARS-COV-2-RELATED MORTALITY OF LIVER CANCER PATIENTS: CANCER STAGE MATTERS
EARLY SARS-COV-2-RELATED MORTALITY OF LIVER CANCER PATIENTS: CANCER STAGE MATTERS

Christie Perelló  et al.

Item 1 - 2 / 2
1